Ophthalmologic damages secondary to COVID-19 coronavirus infection are little described. The ocular involvement is probably multiple, ranging from pathologies of the anterior segment such as conjunctivitis and anterior uveitis to disorders that threaten vision such as retinitis or optic neuropathy. On the other hand, in addition to this impairment, when patients are hospitalized for acute respiratory failure, complications related to possible resuscitation, medication prescriptions, positioning and oxygenation. COVID-19 itself, has several components: - An apoptotic action of the viral attack which will generate cellular destruction, whether pulmonary, cardiac or renal or maybe ocular - A secondary autoimmune action with the development of major vascular inflammation, possibly reaching the retinal, choroidal, and optic nerve vessels. A secondary "hyper" inflammatory syndrome with flashing hypercytokinemia and multi-organ decompensation is described in 3,7% to 4 ,3% of severe cases. - A thromboembolic action
Upon discharge from hospital for COVID-19 infection (or during a telephone call for patients
already discharged at the start of the study), patients will be informed of the study. An
ophthalmology appointment will be given to them between 4 and 6 months after their discharge.
During the ophthalmology appointment, the patient's clinical data will be collected during an
interview (medical and treatment history, blood group). The patient will benefit from a full
ophthalmological examination.
Procedure: Ophthalmologic exam
Visual acuity (ETDRS exam)
Slit lamp examination : fluorescein test, Oxford score, break up time, Schirmer II test
Lipiview
Eye pressure measurement (air tonometer)
Wide field retinophotography
Multicolor and auto-fluorescence retinophotography
Indocyanine green retinal angiography
Optical coherence tomography (OCT) B posterior pole scan
OCT Angiography (OCT-A) of the optic nerve and posterior pole
Adaptive optics
Visual field (Humphrey)
Inclusion Criteria:
- Patients having been hospitalized for a confirmed COVID-19 infection (CT-scanner or
PCR- Polymerase chain reaction)
Exclusion Criteria:
- Pregnant or breastfeeding woman
Fondation A de Rothschild
Paris, France
Martine MAUGET FAYSSE, MD, Principal Investigator
Fondation A. de Rothschild